TrialPloS one2016

Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial.

J R Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.